Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lakshmi Nayak, MD
CONTACT
DFCI Clinical Trials Hotline
CONTACT
Lead
Dana-Farber Cancer Institute
With
This is an open label, pilot trial of Pembrolizumab in combination with chemotherapy in participants with newly diagnosed Primary Central Nervous System Lymphoma (PCNSL). The U.S. Food and Drug Administration (FDA) has not approved Pembrolizumab for Primary Central Nervous System Lymphoma (PCNSL) but it has been approved for other uses. The FDA has approved Rituximab for PCNSL. The FDA has not approved Temozolomide for PCNSL but it has been approved for other uses. The FDA has not approved Methotrexate for PCNSL but it has been approved for other uses. The research study procedures include screening for eligibility, blood and urine tests, Computerized Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, Positron Emission Tomography (PET) scans, testicular ultrasounds, electrocardiograms (ECG), and eye exams. It is expected that about 15 people will take part in this research study. Merck \& Co. is supporting this research study by providing the study drug pembrolizumab.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
